Clinical Study to Evaluate the Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter

Boston Scientific Corporation0 sites160 target enrollmentJanuary 2004

ConditionsAtrial Flutter

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Atrial Flutter
Sponsor: Boston Scientific Corporation
Enrollment: 160
Primary Endpoint: Acute efficacy
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter.

Detailed Description

Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy. Cryoablation is a newer alternative to radiofrequency ablations. This study expands the prior pilot experience with the CryoCor™ Cardiac Cryoablation System to a larger cohort of patients with atrial flutter.

Registry

clinicaltrials.gov

Start Date

January 2004

End Date

June 2005

Last Updated

15 years ago

Study Type

Interventional

Study Design

Single Group